CareDx Statistics
Total Valuation
CareDx has a market cap or net worth of $423.03 million. The enterprise value is $210.13 million.
| Market Cap | 423.03M |
| Enterprise Value | 210.13M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CareDx has 51.78 million shares outstanding. The number of shares has increased by 0.83% in one year.
| Shares Outstanding | 51.78M |
| Shares Change (YoY) | +0.83% |
| Shares Change (QoQ) | -1.47% |
| Owned by Insiders (%) | 3.75% |
| Owned by Institutions (%) | 100.32% |
| Float | 50.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.49 |
| Forward PS | 1.54 |
| PB Ratio | 1.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.02, with a Debt / Equity ratio of 0.11.
| Current Ratio | 4.02 |
| Quick Ratio | 3.68 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 17.02 |
Financial Efficiency
Return on equity (ROE) is -51.40% and return on invested capital (ROIC) is -70.22%.
| Return on Equity (ROE) | -51.40% |
| Return on Assets (ROA) | -37.80% |
| Return on Capital (ROIC) | -70.22% |
| Revenue Per Employee | $441,455 |
| Profits Per Employee | -$299,660 |
| Employee Count | 635 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 5.27 |
Taxes
In the past 12 months, CareDx has paid $141,000 in taxes.
| Income Tax | 141,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.03% in the last 52 weeks. The beta is 1.45, so CareDx's price volatility has been higher than the market average.
| Beta (1Y) | 1.45 |
| 52-Week Price Change | -11.03% |
| 50-Day Moving Average | 9.65 |
| 200-Day Moving Average | 9.14 |
| Relative Strength Index (RSI) | 34.75 |
| Average Volume (30 Days) | 903,388 |
Short Selling Information
The latest short interest is 5.18 million, so 10.00% of the outstanding shares have been sold short.
| Short Interest | 5.18M |
| Short Previous Month | 4.36M |
| Short % of Shares Out | 10.00% |
| Short % of Float | 10.28% |
| Short Ratio (days to cover) | 5.03 |
Income Statement
In the last 12 months, CareDx had revenue of $280.32 million and -$190.28 million in losses. Loss per share was -$3.54.
| Revenue | 280.32M |
| Gross Profit | 178.33M |
| Operating Income | -203.36M |
| Pretax Income | -190.14M |
| Net Income | -190.28M |
| EBITDA | -182.19M |
| EBIT | -202.01M |
| Loss Per Share | -$3.54 |
Balance Sheet
The company has $236.00 million in cash and $28.28 million in debt, giving a net cash position of $207.73 million or $4.01 per share.
| Cash & Cash Equivalents | 236.00M |
| Total Debt | 28.28M |
| Net Cash | 207.73M |
| Net Cash Per Share | $4.01 |
| Equity / Book Value | 261.33M |
| Book Value Per Share | 5.05 |
| Working Capital | 235.64M |
Cash Flow
In the last 12 months, operating cash flow was -$18.39 million and capital expenditures -$8.34 million, giving a free cash flow of -$26.73 million.
| Operating Cash Flow | -18.39M |
| Capital Expenditures | -8.34M |
| Free Cash Flow | -26.73M |
| FCF Per Share | -$0.50 |
Margins
Gross margin is 63.61%, with operating and profit margins of -72.55% and -67.88%.
| Gross Margin | 63.61% |
| Operating Margin | -72.55% |
| Pretax Margin | -67.83% |
| Profit Margin | -67.88% |
| EBITDA Margin | -64.99% |
| EBIT Margin | -72.06% |
| FCF Margin | -9.54% |
Dividends & Yields
CareDx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.83% |
| Shareholder Yield | -0.83% |
| Earnings Yield | -45.54% |
| FCF Yield | -6.40% |
Analyst Forecast
The average price target for CareDx is $13.50, which is 65.44% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.50 |
| Price Target Difference | 65.44% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CareDx has an Altman Z-Score of -1.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.04 |
| Piotroski F-Score | 2 |